Efficacy and Safety of Telitacicept for Prevention of Flares in SLE Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This study is a randomized, double-blind, placebo-controlled single-center clinical trial. The aim of this study is to investigate the efficacy and safety of low-dose telitacicept for prevention of flares in SLE patients with low disease activity.
Epistemonikos ID: ab5cb55436fc7ca5edcdcc55e0989deef8378823
First added on: May 16, 2024